Published in Brain on June 05, 2008
Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med (2011) 4.02
The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol (2012) 3.07
Will the real multiple sclerosis please stand up? Nat Rev Neurosci (2012) 1.61
The pathological spectrum of CNS inflammatory demyelinating diseases. Semin Immunopathol (2009) 1.29
Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol (2013) 1.18
Fulminant demyelinating diseases. Neurohospitalist (2013) 1.10
Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge. Case Rep Radiol (2012) 1.10
Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour. J Neurol (2010) 1.02
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment. Ther Adv Neurol Disord (2015) 0.91
Pathologic heterogeneity persists in early active multiple sclerosis lesions. Ann Neurol (2014) 0.91
Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol (2013) 0.88
Tumefactive Multiple Sclerosis presenting as Acute Ischemic Stroke. J Vasc Interv Neurol (2011) 0.87
Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. J Neurol (2013) 0.86
Teaching NeuroImages: demyelinating disease mimicking butterfly high-grade glioma. Neurology (2010) 0.85
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology. J Neurol (2014) 0.84
A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann's syndrome. BMC Neurol (2014) 0.84
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis. Int J MS Care (2015) 0.83
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report. J Med Case Rep (2012) 0.82
Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions. World J Clin Cases (2015) 0.82
Acute hemorrhagic leukoencephalitis (Weston-Hurst syndrome) in a patient with relapse-remitting multiple sclerosis. J Neuroinflammation (2015) 0.82
Tumefactive multiple sclerosis: an uncommon diagnostic challenge. J Chiropr Med (2010) 0.81
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study. J Neurol (2015) 0.81
An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav (2015) 0.80
Tumefactive multiple sclerosis in Taiwan. PLoS One (2013) 0.80
Neuroradiological evaluation of demyelinating disease. Ther Adv Neurol Disord (2013) 0.80
Medulloblastoma and gliomatosis cerebri: rare brain tumors in multiple sclerosis patients. Neurol Sci (2011) 0.80
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis. Neurol Sci (2016) 0.79
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report. Oncol Lett (2016) 0.79
Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis. Neurohospitalist (2013) 0.78
Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy. Neurotherapeutics (2013) 0.78
The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis. Mult Scler Int (2015) 0.78
Tumefactive demyelination of the spinal cord: a case report. Spinal Cord (2015) 0.78
Cerebral tumefactive demyelinating lesions. Oncol Lett (2015) 0.77
Clinicopathological considerations in acute disseminated encephalomyelitis (ADEM): a fulminant case with favorable outcome. J Neurol (2011) 0.77
Multiple sclerosis and oligodendroglioma: an exceptional association. Case Rep Neurol Med (2014) 0.75
Clinical-radiological-pathological spectrum of central nervous system-idiopathic inflammatory demyelinating disease in the elderly. Mult Scler (2016) 0.75
Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis. Intern Med (2017) 0.75
ADvanced IMage Algebra (ADIMA): a novel method for depicting multiple sclerosis lesion heterogeneity, as demonstrated by quantitative MRI. Mult Scler (2012) 0.75
Language impairment and right hemiparesis in a 54-year-old woman. Front Neurol (2011) 0.75
Tumefactive demyelinating disease with isolated spinal cord involvement. Acta Radiol Short Rep (2014) 0.75
Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices. Curr Neurol Neurosci Rep (2016) 0.75
Differential diagnosis of a vanishing brain space occupying lesion in a child. World J Clin Cases (2015) 0.75
When Evaluating a New Thyroid Mass and a Ring-Enhancing Brain Lesion (When Two Presentations Collide). Cureus (2016) 0.75
Tumefactive demyelination: an unusual cause of a spontaneously resolving homonymous hemianopia. BMJ Case Rep (2013) 0.75
Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels. Case Rep Neurol (2016) 0.75
Contralateral recurrence of tumefactive demyelination. Neuroradiol J (2015) 0.75
Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes. BMC Cancer (2017) 0.75
Evolution of tumefactive lesions in multiple sclerosis: a 12-year study with serial imaging in a single patient. Mult Scler (2013) 0.75
Neuroimaging of tumefactive multiple sclerosis with atypical features. Radiol Case Rep (2015) 0.75
A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review. Medicine (Baltimore) (2016) 0.75
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis. Indian J Crit Care Med (2015) 0.75
Commentary: Tumefactive Demyelinating Lesions as a First Clinical Event: Clinical, Imaging, and Follow-up Observations. Front Neurol (2016) 0.75
Post-traumatic acute disseminated encephalomyelitis. Radiol Case Rep (2015) 0.75
Is size an essential criterion to define tumefactive plaque? MR features and clinical correlation in multiple sclerosis. Neuroradiol J (2016) 0.75
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm. J Clin Diagn Res (2016) 0.75
Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination. BMC Neurol (2016) 0.75
Recurrent tumefactive demyelination: An unusual presentation. J Pediatr Neurosci (2015) 0.75
Multiple sclerosis therapeutic strategies: Start safe and effective, reassess early, and escalate if necessary. Neurol Clin Pract (2011) 0.75
Balò's concentric sclerosis: still to be considered as a variant of multiple sclerosis? Neurol Sci (2015) 0.75
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
What's wrong with Bonferroni adjustments. BMJ (1998) 19.89
Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology (1996) 10.26
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology (1988) 2.52
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology (2002) 2.41
Effect of brain irradiation on demyelinating lesions. Neurology (1993) 2.21
Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol (1993) 2.18
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys (2006) 2.12
Intracranial hematomas: imaging by high-field MR. Radiology (1985) 2.08
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology (1988) 2.03
Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol (2003) 1.92
The appropriateness of analysis of variance and multiple-comparison procedures. Biometrics (1983) 1.89
Open-ring imaging sign: highly specific for atypical brain demyelination. Neurology (2000) 1.80
Baló's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol (2001) 1.78
Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol (2001) 1.75
Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology (2003) 1.56
Pitfalls in the diagnosis of brain tumours. Lancet Neurol (2006) 1.45
Multiple sclerosis with clinical and radiological features of cerebral tumour. J Neurol Neurosurg Psychiatry (1982) 1.45
Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology. Neuroradiology (2006) 1.44
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a. Ann Neurol (2003) 1.39
Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry (1975) 1.38
Tumefactive demyelinating lesions. Neuroradiology (1996) 1.32
The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology (1999) 1.31
Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology (2004) 1.30
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol (2004) 1.25
The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis. Ann Neurol (1991) 1.20
Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand (1992) 1.18
Oligoclonal band number as a marker for prognosis in multiple sclerosis. Arch Neurol (2001) 1.18
Multiple sclerosis mimicking primary brain tumor. Arch Pathol Lab Med (1987) 1.18
MR imaging of brain abscesses. AJR Am J Roentgenol (1989) 1.16
Multiple sclerosis after age 50. Neurology (1983) 1.13
MR imaging of intracranial tuberculomas. J Comput Assist Tomogr (1988) 1.12
Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiatry (1990) 1.09
CT ring sign imitating tumour, disclosed as multiple sclerosis by MRI: a case report. J Neurol Neurosurg Psychiatry (1989) 1.08
Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol (2002) 1.06
The open ring. A new imaging sign in demyelinating disease. J Neuroimaging (1996) 1.06
Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry (1980) 1.05
A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 1.02
Multiple sclerosis: pseudotumoral forms. Neurol Sci (2004) 1.01
Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry (2005) 1.01
Sentinel lesions of primary CNS lymphoma. J Neurol Neurosurg Psychiatry (1996) 1.01
A case of multiple sclerosis with multi-ring-like and butterfly-like enhancement on computerized tomography. Brain Dev (1985) 1.00
Demyelinating disease versus tumor in surgical neuropathology. Clues to a correct pathological diagnosis. Am J Surg Pathol (1993) 1.00
Multiple sclerosis masquerading as a mass lesion. Neuroradiology (1992) 0.98
Aphasia in multiple sclerosis. Neurology (1977) 0.98
Cerebral multiple sclerosis. Neurology (1971) 0.98
Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology (1991) 0.97
Acute focal demyelinating disease simulating brain tumors: histopathologic guidelines for an accurate diagnosis. Neuropathology (2001) 0.96
Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiatry (1991) 0.96
Distinct supratentorial lesions mimicking cerebral gliomas. Acta Neurochir (Wien) (2003) 0.93
Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology (1998) 0.93
Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol (2001) 0.92
Balo's concentric sclerosis: a clinical case study of brain MRI, biopsy, and proton magnetic resonance spectroscopic findings. J Neurol Neurosurg Psychiatry (1997) 0.92
Multiple sclerosis and brain tumor: a diagnostic challenge. J Emerg Med (1989) 0.91
Tumefactive demyelinating lesions: conventional and advanced magnetic resonance imaging. Mult Scler (2005) 0.91
Late-onset multiple sclerosis mimicking brain tumor: a case report. Brain Tumor Pathol (2004) 0.91
Natural history of multiple sclerosis: implications for counselling and therapy. Curr Opin Neurol (2002) 0.90
MR imaging of multiple sclerosis simulating brain tumor. Clin Imaging (1997) 0.89
Inflammatory demyelinating disease mimicking malignant glioma. J Nucl Med (2003) 0.87
Homonymous hemianopia in multiple sclerosis. With report of bilateral case. Br J Ophthalmol (1975) 0.87
Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging. Radiology (1987) 0.86
Tumor-like multiple sclerosis (MS) lesions: neuropathological clues. Neurol Sci (2001) 0.86
Computerized tomography in the diagnostic evaluation of multiple sclerosis. Ann Neurol (1979) 0.86
Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group. J Neurol Sci (1998) 0.86
Incidence of seizures in patients with multiple sclerosis: a population-based study. Mayo Clin Proc (2002) 0.85
Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand (1992) 0.84
Cerebrospinal fluid in acute optic neuritis: experience of the optic neuritis treatment trial. Neurology (1996) 0.84
Therapeutic plasma exchange for acute inflammatory demyelinating syndromes of the central nervous system. J Clin Apher (1999) 0.84
Primary demyelinating disease simulating glioma of the corpus callosum: report of three cases. J Neurosurg (1981) 0.83
Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up. Acta Neurol Scand (1991) 0.83
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. J Neurol Sci (2006) 0.83
"Tumor-mimicking" multiple sclerosis. Clin Neuropathol (2003) 0.83
A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.83
Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg (2004) 0.82
Multiple sclerosis simulating a mass lesion. J Neuroophthalmol (2000) 0.82
Fulminant form of multiple sclerosis simulating brain tumor: a case with parkinsonian features and pathologic study. Arq Neuropsiquiatr (1995) 0.82
Tumefactive multiple sclerosis plaque. J Neurol Neurosurg Psychiatry (2002) 0.81
Transitional multiple sclerosis (Schilder's disease): a case report. J Neurol (2000) 0.81
Bilateral demyelinating tumefactive lesions in three children with hemiparesis. J Child Neurol (2002) 0.81
Acute demyelination, neuropathological diagnosis, and clinical evolution. J Neuropathol Exp Neurol (2000) 0.80
Demyelinating disease of corpus callosum presenting as glioma on magnetic resonance scan: a case documented with pathological findings. Neurosurgery (1987) 0.79
Large demyelinating brain lesion mimicking a herniating tumor. Neurol Sci (2001) 0.79
Conventional MRI and magnetisation transfer imaging of tumour-like multiple sclerosis in a child. Neuroradiology (2002) 0.79
Myelinoclastic diffuse sclerosis (Schilder's disease): report of a case and review of the literature. Br J Neurosurg (2002) 0.78
Tumoral multiple sclerosis of the cerebellum in a child. AJNR Am J Neuroradiol (1995) 0.78
Balo's concentric sclerosis. Report of two patients with magnetic resonance imaging follow-up. J Neuroimaging (1996) 0.78
Higher cerebral dysfunction in a case with atypical multiple sclerosis with concentric lesions. Psychiatry Clin Neurosci (1996) 0.78
Correlation between neuroradiological and electrophysiological investigations in multiple sclerosis with features of a cerebral tumour. Acta Neurol (Napoli) (1994) 0.77
Fulminant multiple sclerosis. AJNR Am J Neuroradiol (1992) 0.77
Focal plaque of demyelination mimicking cerebral tumor in a pediatric patient. Pediatr Neurosurg (1998) 0.77
Tumor-like presentation of multiple sclerosis. Saudi Med J (2000) 0.77
Balò's concentric sclerosis: MRI. Neuroradiology (1996) 0.77
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol (2000) 9.73
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer (1986) 8.57
The new WHO classification of brain tumours. Brain Pathol (1993) 7.16
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol (1997) 6.02
Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol (2003) 5.17
Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology (2002) 4.50
Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology (2008) 4.31
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology (2007) 3.83
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain (2007) 3.82
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol (2000) 3.61
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology (2006) 3.60
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest (1994) 3.58
Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer (1997) 3.58
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology (2009) 3.43
Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology (2004) 3.41
Neuromyelitis optica unique area postrema lesions: nausea, vomiting, and pathogenic implications. Neurology (2011) 3.30
NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology (2008) 3.21
Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res (1989) 3.10
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys (1998) 2.99
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97
Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol (1988) 2.93
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst (2001) 2.90
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain (2000) 2.90
Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain (2005) 2.88
Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med (1999) 2.84
Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain (2008) 2.83
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology (1999) 2.81
Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity (2001) 2.77
Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol (1993) 2.75
MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology (2008) 2.69
Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am J Hum Genet (1996) 2.67
Meningeal hemangiopericytoma: histopathological features, treatment, and long-term follow-up of 44 cases. Neurosurgery (1989) 2.66
Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol (1996) 2.58
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol (1999) 2.47
[Orthopedic spinal surgery]. Ugeskr Laeger (1997) 2.47
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology. Neurology (2008) 2.45
The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature (1995) 2.44
IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol (1998) 2.44
Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery (1988) 2.41
Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol (1996) 2.41
"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer (1999) 2.40
Immune reconstitution inflammatory syndrome after withdrawal of natalizumab? Neurology (2010) 2.36
Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol (1995) 2.34
Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev (1997) 2.32
Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg (1987) 2.32
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32
Remote cerebellar hemorrhage after supratentorial surgery. Neurosurgery (2001) 2.30
Frontotemporal brain sagging syndrome: an SIH-like presentation mimicking FTD. Neurology (2011) 2.27
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med (2001) 2.27
Prognostic value of myoclonus status in comatose survivors of cardiac arrest. Ann Neurol (1994) 2.25
FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging (2001) 2.24
A shared antigenic determinant between natural killer cells and nervous tissue. Nature (1984) 2.24
Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer (1995) 2.20
Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol (1992) 2.19
Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. Am J Surg Pathol (2000) 2.19
Cutaneous T-cell lymphoma and calcitriol and isotretinoin treatment. Lancet (1995) 2.12
Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol (1991) 2.12
CNS aquaporin-4 autoimmunity in children. Neurology (2008) 2.10
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology (1999) 2.07
Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer (1985) 2.03
Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. N Engl J Med (1987) 2.03
Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders. Lancet (1970) 2.01
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology (2008) 2.01
Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord (2001) 2.00
Thymoma. A clinicopathologic review. Cancer (1987) 1.98
Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. Am J Surg Pathol (1998) 1.97
Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer (1995) 1.97
Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology (2003) 1.97
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (2001) 1.94
Lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron (1984) 1.94
Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol (1993) 1.93
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol (1999) 1.93
Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene (1999) 1.91
Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme? J Neuropathol Exp Neurol (2001) 1.91
Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration. Toxicol Pathol (1999) 1.90
Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol (1997) 1.90
Magnetic resonance imaging-based volume studies in temporal lobe epilepsy: pathological correlations. Ann Neurol (1991) 1.89
Animal models. Ann Neurol (1994) 1.88
Renal lithium excretion in man. Am J Physiol (1968) 1.86
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
Histopathology, classification, and grading of gliomas. Glia (1995) 1.84
Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue. Ann Neurol (1989) 1.83
Intraventricular perineurioma: case report. Neurosurgery (1998) 1.81
Solitary fibrous tumor of the meninges: a lesion distinct from fibrous meningioma. A clinicopathologic and immunohistochemical study. Am J Clin Pathol (1996) 1.81
Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol (1997) 1.79
Hereditary adult-onset Alexander's disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia. Neurology (1995) 1.79
Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology (2008) 1.78
Baló's concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol (2001) 1.78